|
Volumn 21, Issue 17, 2000, Pages 3757-3764
|
Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine
|
Author keywords
Actin cytoskeleton; CEM T lymphoblastic leukemia; Cyclin dependent kinase inhibitor; Glycolysis; Mass spectrometry; Protein synthesis; Two dimensional polyacrylamide gel electrophoresis
|
Indexed keywords
BIOCHEMISTRY;
BIOSYNTHESIS;
CANCER CELLS;
CELL CULTURE;
CELLS;
COMPUTATIONAL ELECTROMAGNETICS;
DISEASES;
ELECTROPHORESIS;
ELECTROSPRAY IONIZATION;
MOLECULAR BIOLOGY;
MULTIVARIANT ANALYSIS;
PATHOLOGY;
PRINCIPAL COMPONENT ANALYSIS;
ACTIN CYTOSKELETON;
CEM T-LYMPHOBLASTIC LEUKEMIA;
CYCLIN-DEPENDENT KINASE INHIBITORS;
GLYCOLYSIS;
LYMPHOBLASTIC LEUKEMIA;
OLOMOUCINE;
PROTEIN SPOTS;
PROTEIN SYNTHESIS;
PROTEOMIC APPROACHES;
TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS;
MASS SPECTROMETRY;
ACTIN;
BOHEMINE;
CYCLIN DEPENDENT KINASE INHIBITOR;
ENOLASE;
GUANOSINE DIPHOSPHATE;
INITIATION FACTOR 5A;
OLOMOUCINE;
PROTEOME;
RHO FACTOR;
TRIOSEPHOSPHATE ISOMERASE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CONTROLLED STUDY;
CYTOSKELETON;
GLYCOLYSIS;
HUMAN;
HUMAN CELL;
LYMPHATIC LEUKEMIA;
PRINCIPAL COMPONENT ANALYSIS;
PROTEIN SYNTHESIS;
T CELL LEUKEMIA;
TANDEM MASS SPECTROMETRY;
|
EID: 0033673332
PISSN: 01730835
EISSN: None
Source Type: Journal
DOI: 10.1002/1522-2683(200011)21:17<3757::AID-ELPS3757>3.0.CO;2-X Document Type: Article |
Times cited : (52)
|
References (30)
|